Skip to main content
SpringerLink
Log in
Book cover

Disorders of the Hand pp 179–200Cite as

Dupuytren’s Disease

  • Chapter
  • First Online:

  • 1755 Accesses

Abstract

Dupuytren’s Disease is a chronic proliferative fibromatosis of the palmar fascias that affects predominantly males of over 50. First signs are nodules and skin pits in the palm of hand. These may progress into cords that ultimately may contract and obstruct extension of the fingers. There is a wide range of treatments available now, some more invasive and surgical, such as (dermo-) fasciectomy, and some less invasive such as needle fasciotomy and collagenase treatment. This chapter summarized the various aspects of the disease, as well as the short and long term effects of the various treatments, their advantages and disadvantages.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Hindocha S, McGrouther DA, Bayat A. Epidemiological evaluation of Dupuytren’s disease incidence and prevalence rates in relation to etiology. Hand (N Y). 2009;4(3):256–69.

    Article  Google Scholar 

  2. Lanting R, Broekstra DC, Werker PM, van den Heuvel ER. A systematic review and meta-analysis on the prevalence of Dupuytren Disease in the general population of western countries. Plast Reconstr Surg. 2014;133(3):593–603.

    Google Scholar 

  3. Burke FD, Dias JJ, Lunn PG, Bradley M. Providing care for hand disorders: trauma and elective. The Derby Hand Unit experience (1989–1990). J Hand Surg Br. 1991;16(1):13–8.

    Article  CAS  PubMed  Google Scholar 

  4. Abe Y, Rokkaku T, Ofuchi S, Tokunaga S, Takahashi K, Moriya H. Dupuytren’s disease on the radial aspect of the hand: report on 135 hands in Japanese patients. J Hand Surg Br. 2004;29(4):359–62.

    Article  CAS  PubMed  Google Scholar 

  5. Slattery D. Review: Dupuytren’s disease in Asia and the migration theory of Dupuytren’s disease. ANZ J Surg. 2010;80(7–8):495–9.

    Article  PubMed  Google Scholar 

  6. Sladicka MS, Benfanti P, Raab M, Becton J. Dupuytren’s contracture in the black population: a case report and review of the literature. J Hand Surg. 1996;21(5):898–9.

    Article  CAS  Google Scholar 

  7. Garrod AE. Concerning pads upon the finger joints and their clinical relationships. Br Med J. 1904;2(2270):8.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  8. Kuehlein B. The influence of Dupuytren’s Disease on trigger fingers and vice versa. In: Eaton C, Seegenschmiedt MH, Bayat A, Gabbiani G, Werker PMN, Wach W, editors. Dupuytren’s Disease and related hyperproliferative disorders. 1st ed. Berlin/Heidelberg: Springer; 2012. p. 249–54.

    Chapter  Google Scholar 

  9. Hueston JT. Recurrent Dupuytren’s contracture. Plast Reconstr Surg. 1963;31:66–9.

    Article  CAS  PubMed  Google Scholar 

  10. Abe Y, Rokkaku T, Ofuchi S, Tokunaga S, Takahashi K, Moriya H. Surgery for Dupuytren’s disease in Japanese patients and a new preoperative classification. J Hand Surg Br. 2004;29(3):235–9.

    Article  CAS  PubMed  Google Scholar 

  11. Hindocha S, Stanley JK, Watson S, Bayat A. Dupuytren’s diathesis revisited: evaluation of prognostic indicators for risk of disease recurrence. J Hand Surg Am. 2006;31(10):1626–34.

    Article  PubMed  Google Scholar 

  12. McFarlane RM. On the origin and spread of Dupuytren’s disease. J Hand Surg Am. 2002;27(3):385–90.

    Article  PubMed  Google Scholar 

  13. Elliot D. The early history of contracture of the palmar fascia. Part 1: the origin of the disease: the curse of the MacCrimmons: the hand of benediction: Cline’s contracture. J Hand Surg Br. 1988;13(3):246–53.

    Article  CAS  PubMed  Google Scholar 

  14. Whaley DC, Elliot D. Dupuytren’s disease: a legacy of the north? J Hand Surg Br. 1993;18(3):363–7.

    Article  CAS  PubMed  Google Scholar 

  15. Elliot D. The early history of contracture of the palmar fascia. Part 2: the revolution in Paris: Guillaume Dupuytren: Dupuytren’s disease. J Hand Surg Br. 1988;13(4):371–8.

    Article  CAS  PubMed  Google Scholar 

  16. Elliot D. The early history of contracture of the palmar fascia. Part 3: the controversy in Paris and the spread of surgical treatment of the disease throughout Europe. J Hand Surg Br. 1989;14(1):25–31.

    Article  CAS  PubMed  Google Scholar 

  17. McGrouther DA. Treatment. In: McFarlane RM, McGrouther DA, Flint MH, editors. Dupuytren’s Disease, biology and treatment. Edinburgh/London/Melbourne/New York: Churchill Livingstone; 1990. p. 295–310.

    Google Scholar 

  18. Dickie WR, Hughes NC. Dupuytren’s contracture: a review of the late results of radical fasciectomy. Br J Plast Surg. 1967;20(3):311–4.

    Article  CAS  PubMed  Google Scholar 

  19. Lermusiaux JL, Debeyre N. Le traitement médical de la maladie de Dupuytren. Rev Rhum Mal Osteoartic. 1977;44(11):633–8.

    Google Scholar 

  20. Hurst LC, Badalamente MA, Hentz VR, Hotchkiss RN, Kaplan FT, Meals RA, et al. Injectable collagenase clostridium histolyticum for Dupuytren’s contracture. N Engl J Med. 2009;361(10):968–79.

    Article  CAS  PubMed  Google Scholar 

  21. Betz N, Ott OJ, Adamietz B, Sauer R, Fietkau R, Keilholz L. Radiotherapy in early-stage Dupuytren’s contracture. Long-term results after 13 years. Strahlenther Onkol. 2010;186(2):82–90.

    Article  PubMed  Google Scholar 

  22. Brandt KE. An evidence-based approach to Dupuytren’s contracture. Plast Reconstr Surg. 2010;126(6):2210–5.

    Article  CAS  PubMed  Google Scholar 

  23. Tripoli M, Cordova A, Moschella F. Dupuytren’s contracture as result of prolonged administration of phenobarbital. Eur Rev Med Pharmacol Sci. 2011;15(3):299–302.

    CAS  PubMed  Google Scholar 

  24. Mikkelsen OA. Dupuytren’s disease – the influence of occupation and previous hand injuries. Hand. 1978;10(1):1–8.

    Article  CAS  PubMed  Google Scholar 

  25. Khan AA, Rider OJ, Jayadev CU, Heras-Palou C, Giele H, Goldacre M. The role of manual occupation in the aetiology of Dupuytren’s disease in men in England and Wales. J Hand Surg Br. 2004;29(1):12–4.

    Article  CAS  PubMed  Google Scholar 

  26. Descatha A, Jauffret P, Chastang JF, Roquelaure Y, Leclerc A. Should we consider Dupuytren’s contracture as work-related? A review and meta-analysis of an old debate. BMC Musculoskelet Disord. 2011;12:96.

    Article  PubMed Central  PubMed  Google Scholar 

  27. Bayat A, Stanley JK, Watson JS, Ferguson MW, Ollier WE. Genetic susceptibility to Dupuytren’s disease: transforming growth factor beta receptor (TGFbetaR) gene polymorphisms and Dupuytren’s disease. Br J Plast Surg. 2003;56(4):328–33.

    Article  CAS  PubMed  Google Scholar 

  28. Bayat A, Watson JS, Stanley JK, Ferguson MW, Ollier WE. Genetic susceptibility to Dupuytren disease: association of Zf9 transcription factor gene. Plast Reconstr Surg. 2003;111(7):2133–9.

    Article  PubMed  Google Scholar 

  29. Dolmans GH, Werker PM, Hennies HC, Furniss D, Festen EA, Franke L, et al. Wnt signaling and Dupuytren’s disease. N Engl J Med. 2011;365:307–17.

    Article  CAS  PubMed  Google Scholar 

  30. Degreef I, De Smet L, Sciot R, Cassiman JJ, Tejpar S. Immunohistochemical evidence for Zic1 coexpression with beta-catenin in the myofibroblast of Dupuytren disease. Scand J Plast Reconstr Surg Hand Surg. 2009;43(1):36–40.

    Article  PubMed  Google Scholar 

  31. Dolmans GH, de Bock GH, Werker PM. Dupuytren diathesis and genetic risk. J Hand Surg Am. 2012;37(10):2106–11.

    Article  PubMed  Google Scholar 

  32. Rayan GM. Clinical presentation and types of Dupuytren’s disease. Hand Clin. 1999;15(1):87–96, vii.

    CAS  PubMed  Google Scholar 

  33. Eaton C. Percutaneous fasciotomy for Dupuytren’s contracture. J Hand Surg Am. 2011;36(5):910–5.

    Article  PubMed  Google Scholar 

  34. Luck JV. Dupuytren’s contracture; a new concept of the pathogenesis correlated with surgical management. J Bone Joint Surg Am. 1959;41-A(4):635–64.

    CAS  PubMed  Google Scholar 

  35. Gabbiani G, Majno G. Dupuytren’s contracture: fibroblast contraction? An ultrastructural study. Am J Pathol. 1972;66(1):131–46.

    CAS  PubMed Central  PubMed  Google Scholar 

  36. Follonier Castella L, Gabbiani G, McCulloch CA, Hinz B. Regulation of myofibroblast activities: calcium pulls some strings behind the scene. Exp Cell Res. 2010;316(15):2390–401.

    Article  CAS  PubMed  Google Scholar 

  37. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol. 2002;3(5):349–63.

    Article  CAS  PubMed  Google Scholar 

  38. Hinz B, Gabbiani G. Fibrosis: recent advances in myofibroblast biology and new therapeutic perspectives. F1000 Biol Rep. 2010;2:78.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Tyrkko J, Viljanto J. Significance of histopathological findings in Dupuytren’s contracture. Ann Chir Gynaecol Fenn. 1975;64(5):288–91.

    CAS  PubMed  Google Scholar 

  40. Balaguer T, David S, Ihrai T, Cardot N, Daideri G, Lebreton E. Histological staging and Dupuytren’s disease recurrence or extension after surgical treatment: a retrospective study of 124 patients. J Hand Surg Eur Vol. 2009;34(4):493–6.

    Article  CAS  PubMed  Google Scholar 

  41. Iqbal SA, Manning C, Syed F, Kolluru V, Hayton M, Watson S, et al. Identification of mesenchymal stem cells in perinodular fat and skin in Dupuytren’s disease: a potential source of myofibroblasts with implications for pathogenesis and therapy. Stem Cells Dev. 2012;21(4):609–22.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  42. Iselin M. The forms of Dupuytren’s disease. Concours Med. 1955;77(51):4769–71.

    CAS  PubMed  Google Scholar 

  43. Degreef I, De Smet L. A high prevalence of Dupuytren’s disease in Flanders. Acta Orthop Belg. 2010;76(3):316–20.

    PubMed  Google Scholar 

  44. Tubiana R, Michon J, Thomine JM. Scheme for the assessment of deformities in Dupuytren’s disease. Surg Clin North Am. 1968;48(5):979–84.

    CAS  PubMed  Google Scholar 

  45. Tubiana R. Evaluation of deformities in Dupuytren’s disease. Ann Chir Main. 1986;5(1):5–11.

    Article  CAS  PubMed  Google Scholar 

  46. Woodruff MJ, Waldram MA. A clinical grading system for Dupuytren’s contracture. J Hand Surg Br. 1998;23(3):303–5.

    Article  CAS  PubMed  Google Scholar 

  47. McGrouther DA. The microanatomy of Dupuytren’s contracture. Hand. 1982;14(3):215–36.

    Article  CAS  PubMed  Google Scholar 

  48. McFarlane RM. Patterns of the diseased fascia in the fingers in Dupuytren’s contracture. Displacement of the neurovascular bundle. Plast Reconstr Surg. 1974;54(1):31–44.

    Article  CAS  PubMed  Google Scholar 

  49. Skoog T. Dupuytren’s contracture: pathogenesis and surgical treatment. Surg Clin North Am. 1967;47(2):433–44.

    CAS  PubMed  Google Scholar 

  50. Cleland J. On the cutaneous ligaments of the phalanges. J Anat Phys. 1878;12:526.

    Google Scholar 

  51. Grayson J. The cutaneous ligaments of the digits. J Anat. 1941;75(2):164–5.

    CAS  PubMed Central  PubMed  Google Scholar 

  52. Guimberteau JC, Delage JP, McGrouther DA, Wong JK. The microvacuolar system: how connective tissue sliding works. J Hand Surg Eur Vol. 2010;35(8):614–22.

    Article  CAS  PubMed  Google Scholar 

  53. White S. Anatomy of the palmar fascia on the ulnar border of the hand. J Hand Surg Br. 1984;9B:51.

    Google Scholar 

  54. Goyrand G. Nouvelles recherches sur la re’traction permanente des doigts. Mem Acad R Med. 1833;3:489.

    Google Scholar 

  55. Skoog T. Transverse elements of the palmar aponeurosis in Dupuytren’s contracture. Scand J Plast Reconstr Surg. 1967;1:51.

    Article  Google Scholar 

  56. Short WH, Watson HK. Prediction of the spiral nerve in Dupuytren’s contracture. J Hand Surg Am. 1982;7(1):84–6.

    Article  CAS  PubMed  Google Scholar 

  57. Hettiaratchy S, Tonkin MA, Edmunds IA. Spiralling of the neurovascular bundle in Dupuytren’s disease. J Hand Surg Eur Vol. 2010;35(2):103–8.

    Article  CAS  PubMed  Google Scholar 

  58. Ketchum LD, Donahue TK. The injection of nodules of Dupuytren’s disease with triamcinolone acetonide. J Hand Surg Am. 2000;25(6):1157–62.

    Article  CAS  PubMed  Google Scholar 

  59. Herbst M, Regler G. Dupuytren’s contracture. Radiotherapy in the early stages. Strahlentherapie. 1985;161(3):143–7.

    CAS  PubMed  Google Scholar 

  60. Orlando JC, Smith JW, Goulian D. Dupuytren’s contracture: a review of 100 patients. Br J Plast Surg. 1974;27(3):211–7.

    Article  CAS  PubMed  Google Scholar 

  61. Hueston JT. Table top test. Med J Aust. 1976;2(5):189–90.

    CAS  PubMed  Google Scholar 

  62. Moermans JP. Segmental aponeurectomy in Dupuytren’s disease. J Hand Surg Br. 1991;16(3):243–54.

    Article  CAS  PubMed  Google Scholar 

  63. Moermans JP. Long-term results after segmental aponeurectomy for Dupuytren’s disease. J Hand Surg Br. 1996;21(6):797–800.

    Article  CAS  PubMed  Google Scholar 

  64. Clibbon JJ, Logan AM. Palmar segmental aponeurectomy for Dupuytren’s disease with metacarpophalangeal flexion contracture. J Hand Surg Br. 2001;26(4):360–1.

    Article  CAS  PubMed  Google Scholar 

  65. McCash CR. The open palm technique in Dupuytren’s contracture. Br J Plast Surg. 1964;17:271–80.

    Article  CAS  PubMed  Google Scholar 

  66. Ketchum LD. The use of the full thickness skin graft in Dupuytren’s contracture. Hand Clin. 1991;7(4):731–41; discussion 743.

    CAS  PubMed  Google Scholar 

  67. Armstrong JR, Hurren JS, Logan AM. Dermo-fasciectomy in the management of Dupuytren’s disease. J Bone Joint Surg Br. 2000;82(1):90–4.

    Article  CAS  PubMed  Google Scholar 

  68. Jacobsen K, Holst-Nielsen F. A modified McCash operation for Dupuytren’s contracture. Scand J Plast Reconstr Surg. 1977;11(3):231–3.

    Article  CAS  PubMed  Google Scholar 

  69. van Rijssen AL, Gerbrandy FS, Ter Linden H, Klip H, Werker PM. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren’s disease: a 6-week follow-up study. J Hand Surg Am. 2006;31(5):717–25.

    Article  PubMed  Google Scholar 

  70. Barton NJ. Dupuytren’s disease arising from the abductor digiti minimi. J Hand Surg Br. 1984;9(3):265–70.

    Article  CAS  PubMed  Google Scholar 

  71. Donaldson OW, Pearson D, Reynolds R, Bhatia RK. The association between intraoperative correction of Dupuytren’s disease and residual postoperative contracture. J Hand Surg Eur Vol. 2010;35(3):220–3.

    Article  CAS  PubMed  Google Scholar 

  72. Coert JH, Nerin JP, Meek MF. Results of partial fasciectomy for Dupuytren disease in 261 consecutive patients. Ann Plast Surg. 2006;57(1):13–7.

    Article  CAS  PubMed  Google Scholar 

  73. McFarlane RM, McGrouther DA. Complications and their management. In: McFarlane RM, McGrouther DA, Flint MH, editors. Dupuytren’s disease: biology and treatment. Edinburgh: Churchill Livingstone; 1990. p. 377–82.

    Google Scholar 

  74. Breed CM, Smith PJ. A comparison of methods of treatment of pip joint contractures in Dupuytren’s disease. J Hand Surg Br. 1996;21(2):246–51.

    Article  CAS  PubMed  Google Scholar 

  75. Smith P, Breed C. Central slip attenuation in Dupuytren’s contracture: a cause of persistent flexion of the proximal interphalangeal joint. J Hand Surg Am. 1994;19(5):840–3.

    Article  CAS  PubMed  Google Scholar 

  76. Citron N, Messina JC. The use of skeletal traction in the treatment of severe primary Dupuytren’s disease. J Bone Joint Surg Br. 1998;80(1):126–9.

    Article  CAS  PubMed  Google Scholar 

  77. Bailey AJ, Tarlton JF, Van der Stappen J, Sims TJ, Messina A. The continuous elongation technique for severe Dupuytren’s disease. A biochemical mechanism. J Hand Surg Br. 1994;19(4):522–7.

    Article  CAS  PubMed  Google Scholar 

  78. Goss BC. Summary of literature on skeletal fixation devices for flexion contractures of the PIP joint. 2002. http://www.handbiolab.com/wp-content/themes/handbiolab/files/digitwidget/DW%20Lit%20Summary.pdf.

  79. Craft RO, Smith AA, Coakley B, Casey 3rd WJ, Rebecca AM, Duncan SF. Preliminary soft-tissue distraction vs checkrein ligament release after fasciectomy in the treatment of Dupuytren PIP joint contractures. Plast Reconstr Surg. 2011;128:1107–13.

    Article  CAS  PubMed  Google Scholar 

  80. Badois FJ, Lermusiaux JL, Masse C, Kuntz D. Non-surgical treatment of Dupuytren disease using needle fasciotomy. Rev Rhum Ed Fr. 1993;60(11):808–13.

    CAS  PubMed  Google Scholar 

  81. Pentland AP, Anderson TF. Plantar fibromatosis responds to intralesional steroids. J Am Acad Dermatol. 1985;12(1 Pt 2):212–4.

    Article  CAS  PubMed  Google Scholar 

  82. McMillan C, Binhammer P. Steroid injection and needle aponeurotomy for Dupuytren contracture: a randomized, controlled study. J Hand Surg Am. 2012;37(7):1307–12.

    Article  PubMed  Google Scholar 

  83. Broekstra DC, Werker PM. Steroid injections in combination with needle aponeurotomy as a treatment method for Dupuytren disease: suggestions for increasing the research evidence. J Hand Surg Am. 2012;37(11):2429–30; author reply 2430–1.

    Article  PubMed  Google Scholar 

  84. Coleman S, Gilpin D, Tursi J, Kaufman G, Jones N, Cohen B. Multiple concurrent collagenase clostridium histolyticum injections to Dupuytren’s cords: an exploratory study. BMC Musculoskelet Disord. 2012;13:61. 2474-13-61.

    Article  PubMed Central  PubMed  Google Scholar 

  85. Gilpin D, Coleman S, Hall S, Houston A, Karrasch J, Jones N. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren’s disease. J Hand Surg Am. 2010;35(12):2027–38.e1.

    Article  PubMed  Google Scholar 

  86. Weinzierl G, Flugel M, Geldmacher J. Lack of effectiveness of alternative non-surgical treatment procedures of Dupuytren contracture. Chirurg. 1993;64(6):492–4.

    CAS  PubMed  Google Scholar 

  87. Keilholz L, Seegenschmiedt MH, Sauer R. Radiotherapy for prevention of disease progression in early-stage Dupuytren’s contracture: initial and long-term results. Int J Radiat Oncol Biol Phys. 1996;36(4):891–7.

    Article  CAS  PubMed  Google Scholar 

  88. Werker PM, Pess GM, van Rijssen AL, Denkler K. Correction of contracture and recurrence rates of dupuytren contracture following invasive treatment: the importance of clear definitions. J Hand Surg Am. 2012;37(10):2095–2105.e7.

    Article  PubMed  Google Scholar 

  89. Leclercq C, Tubiana R. Long-term results of aponeurectomy for Dupuytren’s disease. Chirurgie. 1986;112(3):194–7.

    CAS  PubMed  Google Scholar 

  90. Dias JJ, Braybrooke J. Dupuytren’s contracture: an audit of the outcomes of surgery. J Hand Surg Br. 2006;31(5):514–21.

    Article  CAS  PubMed  Google Scholar 

  91. van Rijssen AL, ter Linden H, Werker PM. Five-year results of a randomized clinical trial on treatment in Dupuytren’s disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg. 2012;129(2):469–77.

    Article  PubMed  CAS  Google Scholar 

  92. Jurisic D, Kovic I, Lulic I, Stanec Z, Kapovic M, Uravic M. Dupuytren’s disease characteristics in Primorsko-goranska County, Croatia. Coll Antropol. 2008;32(4):1209–13.

    PubMed  Google Scholar 

  93. Ketchum LD, Hixson FP. Dermofasciectomy and full-thickness grafts in the treatment of Dupuytren’s contracture. J Hand Surg Am. 1987;12(5 Pt 1):659–64.

    Article  CAS  PubMed  Google Scholar 

  94. Ullah AS, Dias JJ, Bhowal B. Does a ‘firebreak’ full-thickness skin graft prevent recurrence after surgery for Dupuytren’s contracture?: a prospective, randomised trial. J Bone Joint Surg Br. 2009;91(3):374–8.

    Article  CAS  PubMed  Google Scholar 

  95. Foucher G, Medina J, Navarro R. Percutaneous needle aponeurotomy: complications and results. J Hand Surg Br. 2003;28(5):427–31.

    Article  CAS  PubMed  Google Scholar 

  96. van Rijssen AL, Werker PM. Percutaneous needle fasciotomy in Dupuytren’s disease. J Hand Surg Br. 2006;31(5):498–501.

    Article  PubMed  Google Scholar 

  97. Hovius SE, Kan HJ, Smit X, Selles RW, Cardoso E, Khouri RK. Extensive percutaneous aponeurotomy and lipografting: a new treatment for Dupuytren disease. Plast Reconstr Surg. 2011;128(1):221–8.

    Article  CAS  PubMed  Google Scholar 

  98. Peimer CA, Blazar P, Coleman S, Kaplan FT, Smith T, Tursi JP, et al. Dupuytren contracture recurrence following treatment with collagenase clostridium histolyticum (CORDLESS study): 3-year data. J Hand Surg Am. 2013;38(1):12–22.

    Article  PubMed  Google Scholar 

  99. Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren’s disease: 8-year follow-up. J Hand Surg Am. 2010;35(4):534–9. 539.e1.

    Article  PubMed  Google Scholar 

  100. Seegenschmiedt MH. Long term outcome of radiotherapy for early stage Dupuytren’s disease: a phase III Clinical study. In: Eaton C, Seegenschmiedt MH, Bayat A, Gabbiani G, Werker PMN, Wach W, editors. Dupuytren’s Disease and related hyperproliferative disorders. 1st ed. Berlin/Heidelberg: Springer; 2012. p. 349–72.

    Chapter  Google Scholar 

  101. Kuhn MA, Wang X, Payne WG, Ko F, Robson MC. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren’s affected palmar fascia. J Surg Res. 2002;103(2):146–52.

    Article  CAS  PubMed  Google Scholar 

  102. Jemec B, Linge C, Grobbelaar AO, Smith PJ, Sanders R, McGrouther DA. The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation. Chir Main. 2000;19(1):15–22.

    Article  CAS  PubMed  Google Scholar 

  103. Bulstrode NW, Bisson M, Jemec B, Pratt AL, McGrouther DA, Grobbelaar AO. A prospective randomised clinical trial of the intra-operative use of 5-fluorouracil on the outcome of Dupuytren’s disease. J Hand Surg Br. 2004;29(1):18–21.

    Article  CAS  PubMed  Google Scholar 

  104. Degreef I, Tejpar S, De Smet L. Improved postoperative outcome of segmental fasciectomy in Dupuytren disease by insertion of an absorbable cellulose implant. J Plast Surg Hand Surg. 2011;45(3):157–64.

    Article  PubMed  Google Scholar 

  105. van Rijssen AL, Werker PM. Percutaneous needle fasciotomy for recurrent Dupuytren disease. J Hand Surg Am. 2012;37(9):1820–3.

    Article  PubMed  Google Scholar 

  106. Larson D, Jerosch-Herold C. Clinical effectiveness of post-operative splinting after surgical release of Dupuytren’s contracture: a systematic review. BMC Musculoskelet Disord. 2008;9:104.

    Article  PubMed Central  PubMed  Google Scholar 

  107. Herweijer H, Dijkstra PU, Nicolai JP, Van der Sluis CK. Postoperative hand therapy in Dupuytren’s disease. Disabil Rehabil. 2007;29(22):1736–41.

    Article  PubMed  Google Scholar 

  108. Jerosch-Herold C, Shepstone L, Chojnowski AJ, Larson D, Barrett E, Vaughan SP. Night-time splinting after fasciectomy or dermo-fasciectomy for Dupuytren’s contracture: a pragmatic, multi-centre, randomised controlled trial. BMC Musculoskelet Disord. 2011;12(1):136.

    Article  PubMed Central  PubMed  Google Scholar 

  109. Elliott PM, McGrouther DA. Dupuytren’s disease. In: Smith P, editor. Lister’s hand surgery: diagnosis and indication. 4th ed. London: Churchill Livingstone; 2002. p. 527.

    Google Scholar 

  110. Elliott PM, McGrouther DA. The Palm. In: McFarlane RM, MCGrouther DA, Flint MH, editors. Dupuytren’s disease. Biology and treatment, The hand and upper limb series, vol. 5. Edinburgh: Churchill Livingstone; 1990. p. 127–35.

    Google Scholar 

  111. Milford LWJ. Retaining ligaments of the digits of the hand: gross and microscopic anatomical study. Philadelphia: W.B. Saunders Company; 1968.

    Google Scholar 

  112. McFarlane RM. The anatomy of dupuytren’s disease. In: Dupuytren’s disease: biology and treatment. Edinburgh: Churchill Livingstone; 1990. p. 159.

    Google Scholar 

  113. Tubiana R. The hand. Philadelphia: WB Saunders; 1999. p. 436.

    Google Scholar 

  114. McFarlane RM. The finger. In: McFarlane RM, McGrouther DA, Flint MH, editors. Dupuytren’s disease. Edinburgh/London/Melbourne/New York: Churchill Livingstone; 1990.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Plastic Surgery, University of Groningen, University Medical Centre Groningen, Hanzeplein 1, BB81, Groningen, 9700 RB, The Netherlands

    Paul M. N. Werker MD, PhD

Authors
  1. Paul M. N. Werker MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Paul M. N. Werker MD, PhD .

Editor information

Editors and Affiliations

  1. Hall Lane, Appley Bridge, Wrightington Hospital, Wigan, Lancashire, United Kingdom

    Ian A. Trail

  2. St George's Hospital, London, United Kingdom

    Andrew N.M. Fleming

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag London

About this chapter

Cite this chapter

Werker, P.M.N. (2015). Dupuytren’s Disease. In: Trail, I., Fleming, A. (eds) Disorders of the Hand. Springer, London. https://doi.org/10.1007/978-1-4471-6557-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-6557-6_10

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-6556-9

  • Online ISBN: 978-1-4471-6557-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation